VS-6766
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for VS-6766, covering 2025-07-15 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer [Phase 1, Phase 2]